Pricing Log in Create free account
Friday 6 November 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.

Revenue
−7.01%
EPS
−101.0%
Free cash flow
+561.9%
Total debt
−90.1%

Quarter to September 2026, against a year earlier

91.44 4.26 +4.89%
Market cap
$14.8B
P/E
97.3×
Fwd P/E
47.7×
Dividend yield
—
F-score
5/9
Altman Z
2.22
Beneish M
−2.07
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Solventum Corporation (SOLV) Revenue

Alert me on Revenue

Solventum Corporation's revenue for fiscal 2025 was $8.3B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $8.2B. Revenue has risen for 3 consecutive fiscal years. Solventum Corporation ranks 6th of 47 Medical Instruments & Supplies companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $8.3B 0.86%
FY2024 $8.3B 0.70%
FY2023 $8.2B 0.82%
FY2022 $8.1B —

Quarterly newest first

Period Revenue Change
Sep 2026 $1.9B (11.77%)
Jun 2026 $2.2B 10.06%
Mar 2026 $2.0B 0.45%
Dec 2025 $2.0B (4.68%)
11 more quarters

Revenue against peers

Company Revenue
BAX Baxter International Inc. compare $11.6B
SOLV Solventum Corporation $8.2B
AVTR Avantor, Inc. compare $6.6B
BLCO Bausch + Lomb Corporation compare $5.4B
COO The Cooper Companies, Inc. compare $4.2B
ALGN Align Technology, Inc. compare $4.2B
ATR AptarGroup, Inc. compare $4.0B
WST West Pharmaceutical Services, Inc. compare $3.4B
RGEN Repligen Corporation compare $805.6M

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on SOLV